Literature DB >> 7026445

Parasite-derived mitogenic activity for human T cells in Plasmodium falciparum continuous cultures.

J J Ballet, P Druilhe, M A Querleux, C Schmitt, M Agrapart.   

Abstract

Supernatants from Plasmodium falciparum continuous cultures exhibited mitogenic activity against human blood lymphocytes from unsensitized donors. This effect, which was not observed with supernatants from control cultures grown in the absence of the parasites, was dependent upon (i) the concentration of supernatant added to the lymphocyte cultures and (ii) the parasite concentration in the P. falciparum continuous cultures. T cells were the predominant target cells of this mitogenic activity. We observed similar response in lymphocytes from malaria-sensitized individuals to P. falciparum continuous culture material. We also detected a mitogenic activity in parasite-infected erythrocytes from P. falciparum continuous cultures. P. falciparum continuous cultures may provide practical quantities of parasite-derived substances which, presumably, are able to manipulate the immune effector mechanisms of an infected host.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026445      PMCID: PMC350774          DOI: 10.1128/iai.33.3.758-762.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Evidence for a malaria mitogen in human malaria.

Authors:  B M Greenwood; R M Vick
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

2.  Partial characterization of a malaria mitogen.

Authors:  B M Greenwood; A J Oduloju; T A Platts-Mills
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

3.  Lymphocyte transformation in human Plasmodium falciparum malaria.

Authors:  D J Wyler; J J Oppenheim
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

4.  Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiquronium bromide (AET) -treated sheep red blood cells with monkey red blood cells.

Authors:  M A Pellegrino; S Ferrone; A N Theofilopoulos
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

5.  Response of sensitized and unsensitized human lymphocyte subpopulations to Plasmodium falciparum antigens.

Authors:  D J Wyler; H G Herrod; F I Weinbaum
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  Plasmodium falciparum in culture: establishment of additional strains.

Authors:  J B Jensen; W Trager
Journal:  Am J Trop Med Hyg       Date:  1978-07       Impact factor: 2.345

7.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

8.  Plasmodium falciparum in vitro culture: improvements using umbilical cord serum and medium modifications.

Authors:  P Druilhe; P Jacquier; D Lambert; M Gentilini
Journal:  Tropenmed Parasitol       Date:  1980-12
  8 in total
  14 in total

1.  Interactions of CD4+ and CD8+ human T lymphocytes from malaria-unprimed donors with Plasmodium falciparum schizont stage.

Authors:  C Roussilhon; M Agrapart; C Behr; P Dubois; J J Ballet
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

2.  Number of cells from Plasmodium falciparum-immune donors that produce gamma interferon in vitro in response to Pf155/RESA, a malaria vaccine candidate antigen.

Authors:  L Kabilan; M Troye-Blomberg; G Andersson; E M Riley; H P Ekre; H C Whittle; P Perlmann
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus.

Authors:  P K Kataaha; C A Facer; E J Holborow
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

4.  Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro.

Authors:  L Kabilan; M Troye-Blomberg; M E Patarroyo; A Björkman; P Perlmann
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

5.  Antibody to intermediate filaments of the cytoskeleton in the sera of patients with acute malaria.

Authors:  S M Mortazavi-Milani; S S Badakere; E J Holborow
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

6.  In vitro induction of lymphocyte responsiveness by a Strongylus vulgaris-derived mitogen.

Authors:  M Bailey; S Lloyd; S C Martin; E J Soulsby
Journal:  Z Parasitenkd       Date:  1984

7.  Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro.

Authors:  M Troye-Blomberg; H Perlmann; M E Patarroyo; P Perlmann
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

8.  Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum.

Authors:  C Roussilhon; M Agrapart; P Guglielmi; A Bensussan; P Brasseur; J J Ballet
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

9.  Specific proliferative response of human lymphocytes to purified soluble antigens from Plasmodium falciparum in vitro cultures and to antigens from malaria patients' sera.

Authors:  I C Bygbjerg; S Jepsen; T G Theander; N Odum
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

10.  Proliferation induced by Plasmodium falciparum antigen and interleukin-2 production by lymphocytes isolated from malaria-immune individuals.

Authors:  T G Theander; I C Bygbjerg; S Jepsen; M Svenson; A Kharazmi; P B Larsen; K Bendtzen
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.